EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Blood–Brain Barrier Is Unaffected in the Ndufs4−/− Mouse Model of Leigh Syndrome

Robin Reynaud-Dulaurier, Romain Clément, Sara Yjjou, Cassandra Cresson, Yasmina Saoudi, Mathilde Faideau, Michael Decressac iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Robin Reynaud-Dulaurier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Université Grenoble Alpes, 38000 Grenoble, France. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Disease Models, Animal, Electron Transport Complex I, Leigh Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Muscular Dystrophy Association, United Mitochondrial Disease Foundation, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction plays a major role in physiological aging and in many pathological conditions. Yet, no study has explored the consequence of primary mitochondrial deficiency on the blood–brain barrier (BBB) structure and function. Addressing this question has major implications for pharmacological and genetic strategies aimed at ameliorating the neurological symptoms that are often predominant in patients suffering from these conditions. In this study, we examined the permeability of the BBB in the Ndufs4−/− mouse model of Leigh syndrome (LS). Our results indicated that the structural and functional integrity of the BBB was preserved in this severe model of mitochondrial disease. Our findings suggests that pharmacological or gene therapy strategies targeting the central nervous system in this mouse model and possibly other models of mitochondrial dysfunction require the use of specific tools to bypass the BBB. In addition, they raise the need for testing the integrity of the BBB in complementary in vivo models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierDisease Models, AnimalElectron Transport Complex ILeigh DiseaseAnimalsMiceMice, KnockoutMitochondria

Stichwörter der Autor:innen

AAV vectorLeigh syndromeblood–brain barriermitochondrial diseases

Substanzen

Electron Transport Complex INdufs4 protein, mouse

Autor:innen und Institutionen

  • Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Université Grenoble Alpes, 38000 Grenoble, France.

ORCID-Profile: Michael Decressac

Förderung

  • French Muscular Dystrophy Association
  • United Mitochondrial Disease Foundation
  • Agence Nationale de la Recherche
  • Edmond J. Safra Philanthropic Foundation
  • AFM-Téléthon
  • Inserm

Zitieren

APA

Reynaud-Dulaurier, R., Clément, R., Yjjou, S., Cresson, C., Saoudi, Y., Faideau, M., & Decressac, M. (2024). The Blood–Brain Barrier Is Unaffected in the Ndufs4−/− Mouse Model of Leigh Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094828

Vancouver

Reynaud-Dulaurier R, Clément R, Yjjou S, Cresson C, Saoudi Y, Faideau M, et al. The Blood–Brain Barrier Is Unaffected in the Ndufs4−/− Mouse Model of Leigh Syndrome. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094828

BibTeX
@article{ReynaudDulaurier2024,
  author = {Reynaud-Dulaurier, Robin and Clément, Romain and Yjjou, Sara and Cresson, Cassandra and Saoudi, Yasmina and Faideau, Mathilde and Decressac, Michael},
  title = {The Blood–Brain Barrier Is Unaffected in the Ndufs4−/− Mouse Model of Leigh Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094828}
}
Kostenlos starten →